Furthermore, by comparing PD patients with (medication group) or without (de novo group) medicine treatment, we found that HIP2 mRNA level was decreased in de novo PD patients and that the HIP2 expression was not affected by levodopa-related medical treatment (Supplementary S3C, D). Here, UBE2K is linked to Parkinson disease.